Cord blood banking is expensive. Preserving cord blood is a process that depends on highly skilled personnel and very sophisticated equipment. Operating costs are high. Upfront investments for both public and private are significant.
In recent years, the increase in regulations have created new challenges for those running public and private banks. Public banks are counting every penny while trying to offer the option to donate cord blood to as many parents as possible. Some private banks have pursued hybrid models in order to serve parents who want to donate as well as those who wish to privately bank. The hybrid model presents both challenges and opportunities when considering operating costs. Meanwhile, private banks continue to fight rising fierce competition which, in turn, forces them to keep prices as low as possible.
The main question on everyone’s mind is “How can we do this better?”
- Can we lower operating costs?
- How can we recover costs and still help the greater good?
- Can we do something useful with cord blood donations that do not meet the new criteria imposed by public registries?
- Can we take advantage of new operating methods and new transplant methods?
Share the Science welcomes Linda Peltier, Ph.D. from McGill University who will share her expertise on improving operating costs for cord blood banks and how to maximize the potential of cord blood collections. With over 35 years of experience in the different healthcare fields, Peltier has become an authority in clinical and laboratory quality assurance. For the past 12 years, she has specialized in cord blood banking and stem cell processing. (Learn more about the cord blood bank at McGill University Health Centre here.)
Share the Science with Linda Peltier, PhD
“How to Potentialize Donations to Cord Blood Banks”
RECORDED: Friday, December 2nd, 11 a.m. – 12 p.m, Central Time
Free webinar. Open to the public.
In this free webinar, Peltier will discuss how public cord blood banks were initially established to store optimal units for allogeneic hematopoietic stem cell transplant (HSCT). Compliance with new regulations and transplant physician requests for an increased number of cells per cord blood unit (CBU) increased the processing costs to a point that some public CBBs had to merge or shut down. The current operational model must be modified. Product diversification and better use of each CBU is one approach that could improve the CBB cost recovery model.
Peltier will discuss ways to recover cord blood and tissue components for a better operational cost. Her analysis is based on 1607 CBUs collected by the McGill University Health Centre Clinical Research Cord Blood Bank (MUHC CRCBB). McGill’s bank was able to recover more than 85% of units rejected by the public bank and calculated that making available cord blood plasma for MSC culture could double the revenue of the bank.
This webinar promises to be beneficial to the management teams of both public and private banks. There is opportunity here, especially for those banks who adhere to the highest standards. Techniques taught in this webinar could help put your cord blood bank ahead of the competition while helping the industry as a whole.
* * *
We wish to express our sincere thanks to Linda Peltier for sharing her expertise and insight
on improving operational costs for cord blood banks.
We also wish to thank our generous sponsors, Mediware Inc., who continue to support cord blood education through our “Share the Science” series.